17762 Federal Register / Vol. 80, No. 63 / Thursday, April 2, 2015 / Notices 

Grant (NRSA) waivers, significant 

rebudgeting, 2nd and 3rd no cost 

extensions, and change of scope. These 

are all prior approvals as required by the 

NIH Grants Policy, and need to be 

reviewed and approved by the NHLBI. 

ePASS will provide a template to ensure 

that all specific points are addressed 

and documented in the official grant 

file. All information is submitted via the 

internet, tracked in ePASS, and the 

documentation will automatically be 

forwarded to the official grant file. The 

system will ensure that individuals 

authorized by the grantee are submitting 

requests and that the appropriate NIH 

staff is receiving the requests. The 

requests will be template driven so that 

the grantee is including the minimally 

required information, thus eliminating 

the usual back and forth to obtain 

missing information. Forms will have 

automatic fill-in capability that will 

reduce typos in grant numbers and PI 

names, further reducing approval time. 

Reminders will be sent to NIH staff 

within ePASS based on roles to ensure 

timely responses to the grantee. The 

system will facilitate email 

communication with applicants by 

automatic notifications when 

applications are received and when NIH 

has made a determination regarding a 

request (approval issued or request 

denied with explanation for denial). 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

470. 

ESTIMATES OF HOUR BURDEN

Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

annual hour 

burden 

NHLBI Grantees .............................................................................................. 940 1 30/60 470 

Totals ........................................................................................................ 940 ........................ ........................ 470 

Dated: March 17, 2015. 

Lynn Susulske, 

NHLBI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2015–07623 Filed 4–1–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Subcommittee on Procedures Review, 

Advisory Board on Radiation and 

Worker Health (ABRWH or Advisory 

Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

aforementioned subcommittee: 

Time and Date: 11:00 a.m.–5:00 p.m., 

Eastern Standard Time, April 28, 2015. 

Place: Audio Conference Call via FTS 

Conferencing. 

Status: Open to the public. The public 

is welcome to submit written comments 

in advance of the meeting, to the contact 

person below. Written comments 

received in advance of the meeting will 

be included in the official record of the 

meeting. The public is also welcome to 

listen to the meeting by joining the 

teleconference at the USA toll-free, dialin number, 1–866–659–0537 and the 

passcode is 9933701. 

Background: The ABRWH was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

compensation program. Key functions of 

the ABRWH include providing advice 

on the development of probability of 

causation guidelines that have been 

promulgated by the Department of 

Health and Human Services (HHS) as a 

final rule; advice on methods of dose 

reconstruction which have also been 

promulgated by HHS as a final rule; 

advice on the scientific validity and 

quality of dose estimation and 

reconstruction efforts being performed 

for purposes of the compensation 

program; and advice on petitions to add 

classes of workers to the Special 

Exposure Cohort (SEC). 

In December 2000, the President 

delegated responsibility for funding, 

staffing, and operating the Advisory 

Board to HHS, which subsequently 

delegated this authority to CDC. NIOSH 

implements this responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

and will expire on August 3, 2015. 

Purpose: The ABRWH is charged with 

(a) providing advice to the Secretary, 

HHS, on the development of guidelines 

under Executive Order 13179; (b) 

providing advice to the Secretary, HHS, 

on the scientific validity and quality of 

dose reconstruction efforts performed 

for this program; and (c) upon request 

by the Secretary, HHS, providing advice 

to the Secretary on whether there is a 

class of employees at any Department of 

Energy facility who were exposed to 

radiation but for whom it is not feasible 

to estimate their radiation dose, and on 

whether there is a reasonable likelihood 

that such radiation doses may have 

endangered the health of members of 

this class. The Subcommittee on 

Procedures Review was established to 

aid the ABRWH in carrying out its duty 

to advise the Secretary, HHS, on dose 

reconstructions. The Subcommittee on 

Procedures Review is responsible for 

overseeing, tracking, and participating 

in the reviews of all procedures used in 

the dose reconstruction process by the 

NIOSH Division of Compensation 

Analysis and Support (DCAS) and its 

dose reconstruction contractor (Oak 

Ridge Associated Universities—ORAU). 

Matters for Discussion: The agenda for 

the Subcommittee meeting includes: 

discussion of procedures in the 

following ORAU and DCAS technical 

documents: Procedures for 

reconstructing dose associated with 

potential skin contamination, ORAU 

Team Technical Information Bulletin 

(OTIB) 0034 (‘‘Internal Dose Coworker 

Data for X–10’’), OTIB 0054 (‘‘Fission 

and Activation Product Assignment for 

Internal Dose-Related Gross Beta and 

Gross Gamma Analyses’’), OTIB 0082 

(‘‘Dose Reconstruction Method for 

Chronic Lymphocytic Leukemia’’), 

Update on Review of ORAU Team 

Report 0053 (‘‘Stratified Co-Worker 

Sets’’); and a continuation of the 

comment-resolution process for other 

dose reconstruction procedures under 

review by the Subcommittee. 

The agenda is subject to change as 

priorities dictate. 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 63 / Thursday, April 2, 2015 / Notices 17763 

Contact Person For More Information: 

Theodore Katz, Designated Federal 

Officer, NIOSH, CDC, 1600 Clifton Road 

NE., Mailstop E–20, Atlanta Georgia 

30333, Telephone (513) 533–6800, Toll 

Free 1(800)CDC–INFO, Email ocas@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–07542 Filed 4–1–15; 8:45 am] 

BILLING CODE CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned committee: 

Time and Date: 8:30 a.m.–3:00 p.m., 

EDT, April 23, 2015. 

Place: CDC, Building 19, Auditorium 

B3, 1600 Clifton Road NE., Atlanta, 

Georgia 30333. 

Status: Open to the public, limited 

only by the space and phone lines 

available. The meeting room 

accommodates approximately 50 

people. Advance registration for inperson participation is required by April 

16, 2015. The public is welcome to 

participate during the public comment 

period, which is tentatively scheduled 

from 2:35 p.m. to 2:40 p.m. This 

meeting will also be available by 

teleconference. Please dial (877) 930– 

8819 and enter code 1579739. 

Web links: Windows Media: http://

wm.onlinevideoservice.com/CDC1. 

Flash: http://

www.onlinevideoservice.com/clients/

CDC/?mount=CDC3. 

If you are unable to connect using the 

link, copy and paste the link into your 

web browser. For technical support 

please call: (404) 639–3737. 

Purpose: The Advisory Committee to 

the Director, CDC, shall advise the 

Secretary, HHS, and the Director, CDC, 

on policy and broad strategies that will 

enable CDC to fulfill its mission of 

protecting health through health 

promotion, prevention, and 

preparedness. The committee 

recommends ways to prioritize CDC’s 

activities, improve results, and address 

health disparities. It also provides 

guidance to help CDC work more 

effectively with its various private and 

public sector constituents to make 

health protection a practical reality. 

Matters for Discussion: The Advisory 

Committee to the Director will receive 

updates from the State, Tribal, Local 

and Territorial Subcommittee; the 

Health Disparities Subcommittee, the 

Global Workgroup, the Internal and 

External Laboratory Safety Workgroups, 

and the Public Health—Health Care 

Collaboration Workgroup, the Ebola 

response, global health security, recent 

viral outbreaks, antimicrobial resistance, 

as well as an update from the CDC 

Director. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Carmen Villar, MSW, Designated 

Federal Officer, ACD, CDC, 1600 Clifton 

Road NE., M/S D–14, Atlanta, Georgia 

30333. Telephone (404) 639–7158, 

Email: GHickman@cdc.gov. The 

deadline to register for in-person 

attendance at this meeting is April 16, 

2015. To register, please send an email 

to GHickman@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. 2015–07543 Filed 4–1–15; 8:45 am] 

BILLING CODE CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10549] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by May 4, 2015: 

ADDRESSES: When commenting on the 

proposed information collections, 

please reference the document identifier 

or OMB control number. To be assured 

consideration, comments and 

recommendations must be received by 

the OMB desk officer via one of the 

following transmissions: OMB, Office of 

Information and Regulatory Affairs, 

Attention: CMS Desk Officer, Fax 

Number: (202) 395–5806 OR, Email: 

OIRA_s submission@omb.eop.gov. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

http://www.cms.hhs.gov/

PaperworkReductionActof1995. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

Reports Clearance Office at (410) 786– 

1326. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 


tkelley on DSK3SPTVN1PROD with NOTICES